Back to search
FDAFDA · Food and drugs·Recall number D-0436-2019

Prednisolone and Gatifloxacin and Bromfenac, Ophthalmic Solution, 1%/0.5%/0.09%, Combo Drops 3 mL, Rx Only, Compounded Prescription, Promise Pharmacy 31818 US Hwy 19N, Palm Harbor FL 34684

Published February 20, 2019 · Recall initiated: December 17, 2018

Summary

FDA records drug Class II recall D-0436-2019, published February 20, 2019 and initiated December 17, 2018. Recalling firm: Promise Pharmacy, LLC; Status: Terminated; Reported quantity: 900 3 ml bottles; Lot: Lots: 11012018@1 BUD: 1/14/2019; 11022018@1 BUD: 1/15/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Promise Pharmacy, LLC
Distributor
Nationwide in the USA.
Lot
Lots: 11012018@1 BUD: 1/14/2019; 11022018@1 BUD: 1/15/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prednisolone and Gatifloxacin and Bromfenac, Ophthalmic Solution, 1%/0.5%/0.09%, Combo Drops 3 mL, Rx Only, Compounded Prescription, Promise Pharmacy 31818 US Hwy 19N, Palm Harbor FL 34684 recalled?

Yes. FDA published recall D-0436-2019 on February 20, 2019. Reported hazard: Lack of sterility assurance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter